These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 23818100)

  • 21. Wernicke-Korsakoff syndrome despite no alcohol abuse: A summary of systematic reports.
    Oudman E; Wijnia JW; Oey MJ; van Dam M; Postma A
    J Neurol Sci; 2021 Jul; 426():117482. PubMed ID: 34000679
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Light therapy for improving cognition, activities of daily living, sleep, challenging behaviour, and psychiatric disturbances in dementia.
    Forbes D; Blake CM; Thiessen EJ; Peacock S; Hawranik P
    Cochrane Database Syst Rev; 2014 Feb; 2014(2):CD003946. PubMed ID: 24574061
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rivastigmine for Alzheimer's disease.
    Birks J; Grimley Evans J; Iakovidou V; Tsolaki M; Holt FE
    Cochrane Database Syst Rev; 2009 Apr; (2):CD001191. PubMed ID: 19370562
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Psychosocial interventions for benzodiazepine harmful use, abuse or dependence.
    Darker CD; Sweeney BP; Barry JM; Farrell MF; Donnelly-Swift E
    Cochrane Database Syst Rev; 2015; 2015(5):CD009652. PubMed ID: 26106751
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Thiamine for Alzheimer's disease.
    Rodríguez-Martín JL; Qizilbash N; López-Arrieta JM
    Cochrane Database Syst Rev; 2001; (2):CD001498. PubMed ID: 11405995
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Light therapy for preventing seasonal affective disorder.
    Nussbaumer B; Kaminski-Hartenthaler A; Forneris CA; Morgan LC; Sonis JH; Gaynes BN; Greenblatt A; Wipplinger J; Lux LJ; Winkler D; Van Noord MG; Hofmann J; Gartlehner G
    Cochrane Database Syst Rev; 2015 Nov; (11):CD011269. PubMed ID: 26558494
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Galantamine for vascular cognitive impairment.
    Birks J; Craig D
    Cochrane Database Syst Rev; 2006 Jan; (4):CD004746. PubMed ID: 23862185
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Diagnostics and treatment of Wernicke-Korsakoff syndrome patients with an alcohol abuse].
    Nilsson M; Sonne C
    Ugeskr Laeger; 2013 Apr; 175(14):942-4. PubMed ID: 23582065
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Wernicke-Korsakoff-syndrome: under-recognized and under-treated.
    Isenberg-Grzeda E; Kutner HE; Nicolson SE
    Psychosomatics; 2012; 53(6):507-16. PubMed ID: 23157990
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Complete recovery from undertreated Wernicke-Korsakoff syndrome following aggressive thiamine treatment.
    Paparrigopoulos T; Tzavellas E; Karaiskos D; Kouzoupis A; Liappas I
    In Vivo; 2010; 24(2):231-3. PubMed ID: 20364001
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prophylactic platelet transfusion for prevention of bleeding in patients with haematological disorders after chemotherapy and stem cell transplantation.
    Estcourt L; Stanworth S; Doree C; Hopewell S; Murphy MF; Tinmouth A; Heddle N
    Cochrane Database Syst Rev; 2012 May; (5):CD004269. PubMed ID: 22592695
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ginseng for cognition.
    Geng J; Dong J; Ni H; Lee MS; Wu T; Jiang K; Wang G; Zhou AL; Malouf R
    Cochrane Database Syst Rev; 2010 Dec; (12):CD007769. PubMed ID: 21154383
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Light therapy for managing cognitive, sleep, functional, behavioural, or psychiatric disturbances in dementia.
    Forbes D; Culum I; Lischka AR; Morgan DG; Peacock S; Forbes J; Forbes S
    Cochrane Database Syst Rev; 2009 Oct; (4):CD003946. PubMed ID: 19821317
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacotherapy for chronic cognitive impairment in traumatic brain injury.
    Dougall D; Poole N; Agrawal N
    Cochrane Database Syst Rev; 2015 Dec; 2015(12):CD009221. PubMed ID: 26624881
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Second-generation antidepressants for preventing seasonal affective disorder in adults.
    Gartlehner G; Nussbaumer B; Gaynes BN; Forneris CA; Morgan LC; Kaminski-Hartenthaler A; Greenblatt A; Wipplinger J; Lux LJ; Sonis JH; Hofmann J; Van Noord MG; Winkler D
    Cochrane Database Syst Rev; 2015 Nov; (11):CD011268. PubMed ID: 26558418
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Psychological, social and welfare interventions for psychological health and well-being of torture survivors.
    Patel N; Kellezi B; Williams AC
    Cochrane Database Syst Rev; 2014 Nov; 2014(11):CD009317. PubMed ID: 25386846
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Integrating prevention of mother-to-child HIV transmission (PMTCT) programmes with other health services for preventing HIV infection and improving HIV outcomes in developing countries.
    Tudor Car L; van-Velthoven MH; Brusamento S; Elmoniry H; Car J; Majeed A; Atun R
    Cochrane Database Syst Rev; 2011 Jun; (6):CD008741. PubMed ID: 21678382
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Psychosocial interventions for preventing and treating depression in dialysis patients.
    Natale P; Palmer SC; Ruospo M; Saglimbene VM; Rabindranath KS; Strippoli GF
    Cochrane Database Syst Rev; 2019 Dec; 12(12):CD004542. PubMed ID: 31789430
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rivastigmine for vascular cognitive impairment.
    Birks J; McGuinness B; Craig D
    Cochrane Database Syst Rev; 2013 May; (5):CD004744. PubMed ID: 23728651
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neuromuscular electrical stimulation (NMES) for patellofemoral pain syndrome.
    Martimbianco ALC; Torloni MR; Andriolo BN; Porfírio GJ; Riera R
    Cochrane Database Syst Rev; 2017 Dec; 12(12):CD011289. PubMed ID: 29231243
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.